Literature DB >> 18223020

The diagnostic accuracy of the Revised Westmead PTA Scale as an adjunct to the Glasgow Coma Scale in the early identification of cognitive impairment in patients with mild traumatic brain injury.

E A Shores1, A Lammél, C Hullick, J Sheedy, M Flynn, W Levick, J Batchelor.   

Abstract

BACKGROUND: Assessment of patients with mild traumatic brain injury (mTBI) is predominantly done using the Glasgow Coma Scale (GCS). While the GCS is universally accepted for assessment of severity of traumatic brain injury, it may not be appropriate to rely on the GCS alone when assessing patients with mTBI in prehospital settings and emergency departments.
OBJECTIVE: To determine whether administering the Revised Westmead Post-traumatic Amnesia (PTA) Scale (R-WPTAS) in addition to the GCS would increase diagnostic accuracy in the early identification of cognitive impairment in patients with mTBI.
METHODS: Data were collected from 82 consecutive participants with mTBI who presented to the emergency department of a level 1 trauma centre in Australia. A matched sample of 88 control participants who attended the emergency department for reasons other than head trauma was also assessed. All patients were assessed using the GCS, R-WPTAS and a battery of neuropsychological tests.
RESULTS: Patients with mTBI scored poorly compared with control patients on all measures. The R-WPTAS showed greater concurrent validity with the neuropsychological measures than the GCS and significantly increased prediction of group membership of patients with mTBI with cognitive impairment.
CONCLUSIONS: The R-WPTAS significantly improves diagnostic accuracy in identifying patients with mTBI who may be in PTA. Administration takes less than 1 min, and since early identification of a patient's cognitive status facilitates management decisions, it is recommended for routine use whenever the GCS is used.

Entities:  

Mesh:

Year:  2008        PMID: 18223020     DOI: 10.1136/jnnp.2007.132571

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  7 in total

1.  Clinical practice guidelines for mild traumatic brain injury and persistent symptoms.

Authors:  Shawn Marshall; Mark Bayley; Scott McCullagh; Diana Velikonja; Lindsay Berrigan
Journal:  Can Fam Physician       Date:  2012-03       Impact factor: 3.275

Review 2.  Validity of the Immediate Post Concussion Assessment and Cognitive Testing (ImPACT).

Authors:  Bara Alsalaheen; Kayla Stockdale; Dana Pechumer; Steven P Broglio
Journal:  Sports Med       Date:  2016-10       Impact factor: 11.136

3.  Development and external validation of a new PTA assessment scale.

Authors:  Bram Jacobs; Janneke van Ekert; Lotje Pl Vernooy; Peter Dieperink; Teuntje M J C Andriessen; Marc P H Hendriks; Arie B van Vugt; Marjolein A A Emons; George F Borm; Pieter E Vos
Journal:  BMC Neurol       Date:  2012-08-08       Impact factor: 2.474

4.  Knockout of Cyclophilin-D Provides Partial Amelioration of Intrinsic and Synaptic Properties Altered by Mild Traumatic Brain Injury.

Authors:  Jianli Sun; Kimberle M Jacobs
Journal:  Front Syst Neurosci       Date:  2016-07-20

5.  Trauma recidivism at an emergency department of a Swedish medical center.

Authors:  Fredrik Röding; Marie Lindkvist; Ulrica Bergström; Olle Svensson; Jack Lysholm
Journal:  Inj Epidemiol       Date:  2016-09-12

6.  Concussion in Non-athletes: Assessment of Cognition and Symptomatology (CONTACTS) study protocol - an exploratory cohort study investigating the utility of sports concussion assessment tools and salivary microRNAs to diagnose concussion in NHS patients.

Authors:  Emma Toman; Max Riley; Sam Hodgson; Kamal M Yakoub; Lauren Cooper; Jon Bishop; David N Naumann; Richard Welbury; Douglas Hammond; Valentina Di Pietro; Antonio Belli
Journal:  BMJ Open       Date:  2022-09-21       Impact factor: 3.006

7.  Implementing evidence-based recommended practices for the management of patients with mild traumatic brain injuries in Australian emergency care departments: study protocol for a cluster randomised controlled trial.

Authors:  Marije Bosch; Joanne E McKenzie; Duncan Mortimer; Emma J Tavender; Jill J Francis; Sue E Brennan; Jonathan C Knott; Jennie L Ponsford; Andrew Pearce; Denise A O'Connor; Jeremy M Grimshaw; Jeffrey V Rosenfeld; Russell L Gruen; Sally E Green
Journal:  Trials       Date:  2014-07-11       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.